Advertisement
Advertisement
U.S. markets close in 4 hours 1 minute
Advertisement
Advertisement
Advertisement
Advertisement

Viemed Healthcare, Inc. (VMD.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
8.15-0.17 (-2.04%)
As of 11:48AM EDT. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close8.32
Open8.34
Bid8.10 x 0
Ask8.16 x 0
Day's Range8.06 - 8.34
52 Week Range4.53 - 10.35
Volume2,870
Avg. Volume42,334
Market Cap311.509M
Beta (5Y Monthly)0.92
PE Ratio (TTM)28.10
EPS (TTM)0.29
Earnings DateOct 31, 2022 - Nov 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for VMD.TO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Simply Wall St.

      Is It Time To Consider Buying Viemed Healthcare, Inc. (TSE:VMD)?

      While Viemed Healthcare, Inc. ( TSE:VMD ) might not be the most widely known stock at the moment, it led the TSX...

    • GlobeNewswire

      Viemed Healthcare Announces Second Quarter 2022 Financial Results

      LAFAYETTE, La., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and six months ended June 30, 2022. Operational highlights (all dollar amounts are USD): Net revenues attributable to the Company's core business for the quarter ended June 30, 2022 were $33.1 million,

    • GlobeNewswire

      Viemed Announces Executive Additions to Lead Acquisition Growth

      LAFAYETTE, La., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced the additions of Michael Freeman as Chief Business Development Officer and Jeremy Trahan as Chief Legal Officer and Executive Vice President of Acquisitions and Strategic Transactions. Prior to joining the team at Viemed, Freeman and Trahan were executives at LHC G

    Advertisement
    Advertisement